If you need more lookups,
subscriptions start at $34 USD/month.
Stephane Berthier Location
United States
Stephane Berthier Work
2024 -now Chief Executive Officer @
2023 -2024 US President and Chief Executive Officer @
2021 -2023 U.S. General Manager @
2019 -2021 Vice President, Head of US Commercial @
2016 -2019 Global Commercial Head, Leukemia and Lymphoma Franchise @
2013 -2016 US Brand lead - Hematology and Oncology @
2011 -2013 Global Brand Director - Hematology and Oncology @
2009 -2011 Associate Director - US Marketing - Hematology and Oncology @
2006 -2009 Oncology Sales - Hematology and Oncology @
2003 -2006 Director - Global Project Manager @
1999 -2003 Laboratory Head in Research and Devlopment @
Stephane Berthier Education
Lancaster University
MBA (Marketing)
2004-2006
Université Paris Cité
MS (Pharmacy)
1990-1997
Stephane Berthier Skills
Oncology
Biotechnology
Brand Management
Business Strategy
Clinical Development
Cross-functional Team Leadership
Global Marketing
Healthcare
Hospital Sales
Market Access
Clinical Trials
Marketing Management
Medical Affairs
Pharmaceutical Industry
Product Launch
Sales Effectiveness
Strategy
Leadership
Microsoft Word
Project Management
Marketing
Lymphoma
Cross Functional Team Leadership
Marketing Strategy
Research
PowerPoint
Leukemia
Stephane Berthier Summary
Stephane Berthier, based in United States, is currently a Chief Executive Officer at SDK Therapeutics. Stephane Berthier brings experience from previous roles at SymBio Pharma USA, Inc., Atara Biotherapeutics, MorphoSys and The Janssen Pharmaceutical Companies of Johnson & Johnson. Stephane Berthier holds a 2004 - 2006 MBA in Marketing @ Lancaster University. With a robust skill set that includes Oncology, Biotechnology, Brand Management, Business Strategy, Clinical Development and more. Stephane Berthier has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Stephane Berthier?
Find contact details for 700 million professionals.